Third-Generation Sequencing Unlocks Insights Into Epigenetics and Biomarkers with Dr. Jonathon Hill Wasatch Bio Labs TRANSCRIPT
Download PDFNov 8, 2024
Dr. Jonathon Hill, VP of Science and Technology and Co-Founder of Wasatch Bio Labs has developed the Next-Generation Sequencing 3.0, NESSI-Seq platform, which can analyze blood to detect epigenetic changes and provide insights into current health and predisposition for diseases. This native-read...
Nov 8, 2024
Dr. Jonathon Hill, VP of Science and Technology and Co-Founder of Wasatch Bio Labs has developed the Next-Generation Sequencing 3.0, NESSI-Seq platform, which can analyze blood to detect epigenetic changes and provide insights into current health and predisposition for diseases. This native-read...
Cell Therapies Drive Immune System in Cures for Solid Tumors and Blood Cancers with Alain Maiore Mnemo Therapeutics TRANSCRIPT
Download PDFAug 2, 2021
Alain Maiore is the Co-Founder and CEO of Mnemo Therapeutics and has a mission to change the future of cell therapy. The Mnemo platform EnfiniT is an integrated drug discovery engine that combines T-cell engineering technologies with greater target identification to transform the body's immune response to overcome...
Aug 2, 2021
Alain Maiore is the Co-Founder and CEO of Mnemo Therapeutics and has a mission to change the future of cell therapy. The Mnemo platform EnfiniT is an integrated drug discovery engine that combines T-cell engineering technologies with greater target identification to transform the body's immune response to overcome...
Targeting Epigenetic Causes of Ewing's Sarcoma with David Arthur Salarius Pharmaceuticals TRANSCRIPT
Download PDFApr 7, 2020
David Arthur, CEO, Salarius Pharmaceuticals explains the role of our epigenome and what happens when someone is suffering from an epigenetic illness such as Ewing's sarcoma. A whole series of cancers can trace their cause back to the body misreading genes and that leads to dysregulation of genetic expression. With few...